| Nome del prodotto |
N-[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]-4,4-dimethyl-3-oxo-2-[4-[[4-(phenylmethoxy)phenyl]sulphonyl]phenoxy]valeramide |
| Nome inglese |
N-[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]-4,4-dimethyl-3-oxo-2-[4-[[4-(phenylmethoxy)phenyl]sulphonyl]phenoxy]valeramide; Pentanamide, N-(5-((4-(2,4-bis(1,1-dimethylpropyl)phenoxy)-1-oxobutyl)amino)-2-chlorophenyl)-4,4-dimethyl-3-oxo-2-(4-((4-(phenylmethoxy)phenyl)sulfonyl)phenoxy)-; N-(5-((4-(2,4-Bis(1,1-dimethylpropyl)phenoxy)-1-oxobutyl)amino)-2-chlorophenyl)-4,4-dimethyl-3-oxo-2-(4-((4-(phenylmethoxy)phenyl)sulphonyl)phenoxy)valeramide; 2-(4-{[4-(benzyloxy)phenyl]sulfonyl}phenoxy)-N-[5-({4-[2,4-bis(2-methylbutan-2-yl)phenoxy]butanoyl}amino)-2-chlorophenyl]-4,4-dimethyl-3-oxopentanamide; 1-(2,4,6-trichlorophenyl)-3-[3-(2,4-di-tert-pentylphenoxy) acetamido]benzamido-5-pyrazolone |
| Formula molecolare |
C52H61ClN2O8S |
| Peso Molecolare |
909.5673 |
| InChI |
InChI=1/C52H61ClN2O8S/c1-10-51(6,7)36-19-30-45(42(32-36)52(8,9)11-2)61-31-15-18-46(56)54-37-20-29-43(53)44(33-37)55-49(58)47(48(57)50(3,4)5)63-39-23-27-41(28-24-39)64(59,60)40-25-21-38(22-26-40)62-34-35-16-13-12-14-17-35/h12-14,16-17,19-30,32-33,47H,10-11,15,18,31,34H2,1-9H3,(H,54,56)(H,55,58) |
| Numero CAS |
30744-85-5 |
| EINECS |
250-321-7 |
| Struttura molecolare |
![30744-85-5 N-[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]-4,4-dimethyl-3-oxo-2-[4-[[4-(phenylmethoxy)phenyl]sulphonyl]phenoxy]valeramide](https://images-a.chemnet.com/suppliers/chembase/cas/cas30744-85-5.gif)
|
| Densità |
1.201g/cm3 |
| Punto di ebollizione |
988.2°C at 760 mmHg |
| Indice di rifrazione |
1.585 |
| Punto d'infiammabilità |
551.4°C |
| Pressione di vapore |
0mmHg at 25°C |
| Simboli di pericolo |
|
| Codici di Rischio |
|
| Sicurezza Descrizione |
|
|
